Maximus, Inc. $MMS Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp cut its stake in Maximus, Inc. (NYSE:MMS) by 61.2% in the fourth quarter, HoldingsChannel reports. The fund owned 9,865 shares of the health services provider’s stock after selling 15,572 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Maximus were worth $852,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of MMS. Farther Finance Advisors LLC lifted its holdings in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares during the period. Richardson Financial Services Inc. lifted its holdings in Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 192 shares during the period. Advisory Services Network LLC acquired a new position in Maximus in the third quarter valued at approximately $32,000. Canada Pension Plan Investment Board acquired a new position in Maximus in the second quarter valued at approximately $35,000. Finally, Cullen Frost Bankers Inc. acquired a new position in Maximus in the third quarter valued at approximately $38,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Trading Up 1.2%

Shares of Maximus stock opened at $65.29 on Wednesday. Maximus, Inc. has a twelve month low of $60.75 and a twelve month high of $100.00. The firm’s 50-day moving average price is $69.11 and its 200 day moving average price is $80.28. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $3.56 billion, a PE ratio of 9.94 and a beta of 0.60.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, topping the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period in the previous year, the business earned $1.61 EPS. Maximus’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, sell-side analysts predict that Maximus, Inc. will post 8.46 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, May 15th. Maximus’s payout ratio is presently 20.09%.

Insider Buying and Selling

In other news, CEO Bruce Caswell purchased 3,175 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was purchased at an average cost of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the transaction, the chief executive officer owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This trade represents a 0.98% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jan Madsen sold 742 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares of the company’s stock, valued at $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

MMS has been the subject of a number of analyst reports. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings cut Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Finally, Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.